These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 6616789

  • 21. Sustained antianginal efficacy of oral high-dose isosorbide dinitrate in patients with coronary heart disease.
    Schneider W, Wietschoreck A, Bussmann WD, Kaltenbach M.
    Z Kardiol; 1983; 72 Suppl 3():259-67. PubMed ID: 6666231
    [Abstract] [Full Text] [Related]

  • 22. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
    Reiniger G, Blasini R, Brügmann U, Rudolph W.
    Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
    [Abstract] [Full Text] [Related]

  • 23. [Anti-angina effectiveness of isosorbide dinitrate in an acute trial and following continuous 4-week therapy with 40 mg 6 times a day].
    Schneider W, Wietschoreck A, Bussmann WD, Kaltenbach M.
    Klin Wochenschr; 1985 May 15; 63(10):460-7. PubMed ID: 3925217
    [Abstract] [Full Text] [Related]

  • 24. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
    Straehl P, Galeazzi RL.
    Clin Pharmacol Ther; 1985 Aug 15; 38(2):140-9. PubMed ID: 4017416
    [Abstract] [Full Text] [Related]

  • 25. Increased exercise tolerance and reduced duration of ischemia after isosorbide dinitrate oral spray in angina pectoris.
    Marmor A, Plich M, Blondheim D, Sharir T, Alpert JS.
    Am J Cardiol; 1988 Mar 25; 61(9):4E-6E. PubMed ID: 3348139
    [Abstract] [Full Text] [Related]

  • 26. [Long-term percutaneous therapy of angina pectoris with isosorbide dinitrate with reference to isosorbide dinitrate blood levels].
    Kriehuber E, Prey T, Orthofer R.
    Wien Med Wochenschr; 1982 Jun 30; 132(12):295-302. PubMed ID: 7123974
    [Abstract] [Full Text] [Related]

  • 27. Comparison of transdermal nitrate and isosorbide dinitrate in chronic stable angina.
    Nicholls DP, Moles K, Gleadhill DN, Booth K, Rowan J, Morton P.
    Br J Clin Pharmacol; 1986 Jul 30; 22(1):15-20. PubMed ID: 3091055
    [Abstract] [Full Text] [Related]

  • 28. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
    Mertens HM, Ohlmeier H, Mannebach H, Kabelitz K, Gleichmann U.
    Herz; 1985 Jun 30; 10(3):172-81. PubMed ID: 3926614
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics and pharmacodynamics of isosorbide dinitrate.
    Fung HL.
    Am Heart J; 1985 Jul 30; 110(1 Pt 2):213-6. PubMed ID: 4013997
    [Abstract] [Full Text] [Related]

  • 30. Preventive administration of intravenous N-acetylcysteine and development of tolerance to isosorbide dinitrate in patients with angina pectoris.
    Boesgaard S, Aldershvile J, Poulsen HE.
    Circulation; 1992 Jan 30; 85(1):143-9. PubMed ID: 1728443
    [Abstract] [Full Text] [Related]

  • 31. Hemodynamic effects of isosorbide dinitrate vs nitroglycerin in patients with unstable angina.
    Willis WH, Russell RO, Mantle JA, Ratshin RA, Rackley CE.
    Chest; 1976 Jan 30; 69(1):15-22. PubMed ID: 811427
    [Abstract] [Full Text] [Related]

  • 32. [Comparative evaluation of antianginal efficacy of isosorbide dinitrate in various doses in patients with stable angina].
    Kośmicki M, Sadowski Z.
    Wiad Lek; 2000 Jan 30; 53(7-8):388-93. PubMed ID: 11070759
    [Abstract] [Full Text] [Related]

  • 33. Response to changing plasma concentrations of isosorbide-bound NO2 during acute and sustained treatment with isosorbide dinitrate in patients with coronary artery disease.
    Jørgensen LH, Thaulow E, Bredesen J, Refsum HE.
    Clin Cardiol; 2000 Jun 30; 23(6):427-32. PubMed ID: 10875033
    [Abstract] [Full Text] [Related]

  • 34. Continuous oral N-acetylcysteine treatment and development of nitrate tolerance in patients with stable angina pectoris.
    Boesgaard S, Aldershvile J, Pedersen F, Pietersen A, Madsen JK, Grande P.
    J Cardiovasc Pharmacol; 1991 Jun 30; 17(6):889-93. PubMed ID: 1714011
    [Abstract] [Full Text] [Related]

  • 35. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate (ISDN) during acute and short-term administration in stable angina pectoris.
    Wagner F, Gohlke-Bärwolf C, Trenk D, Jähnchen E, Roskamm H.
    Eur Heart J; 1991 Sep 30; 12(9):994-9. PubMed ID: 1936012
    [Abstract] [Full Text] [Related]

  • 36. [Pharmacodynamic effects of the sustained-release tablet of isosorbide dinitrate and its bioavailability in conscious dogs (author's transl)].
    Kogi K, Chida S, Kimura T, Saito T.
    Nihon Yakurigaku Zasshi; 1980 Mar 30; 76(2):99-107. PubMed ID: 7399370
    [Abstract] [Full Text] [Related]

  • 37. Effects of sublingual nitrate in patients receiving sustained therapy of isosorbide dinitrate for coronary artery disease.
    Naito H, Matsuda Y, Shiomi K, Yorozu T, Maeda T, Lee H, Seki K, Nakashima H.
    Am J Cardiol; 1989 Sep 15; 64(10):565-8. PubMed ID: 2782246
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of isosorbide dinitrate tape on exercise tolerance of patients with angina pectoris.
    Saito M, Nobuyoshi M, Nakamura N, Nishiyama S, Haze K, Hiramori K, Ikeda M.
    Arzneimittelforschung; 1983 Sep 15; 33(9):1301-5. PubMed ID: 6685512
    [Abstract] [Full Text] [Related]

  • 39. [Tolerance to a sustained release form of isosorbide dinitrate: comparison between 20 mg four times and 40 mg twice-daily administrations].
    Hiasa Y, Hamai K, Wada T, Ootani R, Shinohara H, Aihara T, Bando M, Nakai Y, Kataoka Y.
    Kokyu To Junkan; 1991 Sep 15; 39(9):925-30. PubMed ID: 1749871
    [Abstract] [Full Text] [Related]

  • 40. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
    Markis JE, Gorlin R, Mills RM, Williams RA, Schweitzer P, Ransil BJ.
    Am J Cardiol; 1979 Feb 15; 43(2):265-71. PubMed ID: 367136
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.